APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
Clinical trial NCT00709826 · COMPLETED
Trial details
- NCT number
- NCT00709826
- Sponsor
- Tragara Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-06-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.